Consequently, MITA-1 May promote EMT by upregulating Slug transcription, suggesting that the AMPK/MITA-1/EMT pathway could serve as a potential therapeutic target for hepatocellular carcinoma [65]. The gene discussed is MITA1; the disease is hepatocellular carcinoma.